Financials data is unavailable for this security.
View more
Year on year Coloplast A/S had little change in net income (from 4.71bn to 4.78bn) despite revenues that grew 8.51% from 22.58bn to 24.50bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 31.22% to 33.36%.
Gross margin | 67.52% |
---|---|
Net profit margin | 18.88% |
Operating margin | 26.83% |
Return on assets | 11.87% |
---|---|
Return on equity | 43.17% |
Return on investment | 16.19% |
More ▼
Cash flow in DKKView more
In 2023, Coloplast A/S increased its cash reserves by 120.05%, or 497.00m. Cash Flow from Financing totalled 5.27bn or 21.49% of revenues. In addition the company generated 4.23bn in cash from operations while cash used for investing totalled 8.96bn.
Cash flow per share | 27.78 |
---|---|
Price/Cash flow per share | 30.90 |
Book value per share | 73.49 |
---|---|
Tangible book value per share | -62.48 |
More ▼
Balance sheet in DKKView more
Current ratio | 0.8536 |
---|---|
Quick ratio | 0.5587 |
Total debt/total equity | 1.48 |
---|---|
Total debt/total capital | 0.5975 |
More ▼
Growth rates in DKK
SmartText is unavailable
Div yield(5 year avg) | 2.23% |
---|---|
Div growth rate (5 year) | 5.59% |
Payout ratio (TTM) | 93.76% |
EPS growth(5 years) | 4.16 |
---|---|
EPS (TTM) vs TTM 1 year ago | -1.75 |
More ▼